A Pharmacokinetic Study Investigating the Rate and Extent of Paracetamol Absorption of Three Experimental Sustained Release Pediatric Suspensions

Completed · Phase 1

Conditions studied: Healthy Subjects

In brief

This proof of principle PK study will allow GSKCH to select the most favorable sustained release formulation among 3 prototypes to move to the next stage of drug development.

Key facts

Study ID

NCT01476215

Run by

GlaxoSmithKline

People needed

18

Starts

2009-11-01

Expected to finish

2009-11-01

Last updated by the study team

2014-11-24

Who can join

Age: 19 and older, up to 50. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Healthy volunteer
• Body Mass Index between 19.0 - 28.0 (kg/m2) inclusive

Where it is running

• MDS Pharma Services NEBRASKA — Lincoln, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.